- Home
- FTK vs HQL Comparison
FTK vs HQL Comparison
Compare FTK & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTK
- HQL
- Stock Information
- Founded
- FTK 1985
- HQL 1992
- Country
- FTK United States
- HQL United States
- Employees
- FTK N/A
- HQL N/A
- Industry
- FTK Major Chemicals
- HQL Investment Managers
- Sector
- FTK Industrials
- HQL Finance
- Exchange
- FTK Nasdaq
- HQL Nasdaq
- Market Cap
- FTK 440.6M
- HQL 378.8M
- IPO Year
- FTK N/A
- HQL N/A
- Fundamental
- Price
- FTK $12.68
- HQL $13.73
- Analyst Decision
- FTK Buy
- HQL
- Analyst Count
- FTK 2
- HQL 0
- Target Price
- FTK $12.00
- HQL N/A
- AVG Volume (30 Days)
- FTK 448.4K
- HQL 120.9K
- Earning Date
- FTK 08-05-2025
- HQL 01-01-0001
- Dividend Yield
- FTK N/A
- HQL 11.56%
- EPS Growth
- FTK 82.12
- HQL N/A
- EPS
- FTK 0.43
- HQL 0.79
- Revenue
- FTK $214,211,000.00
- HQL N/A
- Revenue This Year
- FTK $15.92
- HQL N/A
- Revenue Next Year
- FTK $12.67
- HQL N/A
- P/E Ratio
- FTK $29.55
- HQL $17.08
- Revenue Growth
- FTK 21.72
- HQL N/A
- 52 Week Low
- FTK $3.79
- HQL $11.34
- 52 Week High
- FTK $16.87
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- FTK 47.46
- HQL 66.15
- Support Level
- FTK $11.13
- HQL $13.05
- Resistance Level
- FTK $14.42
- HQL $13.31
- Average True Range (ATR)
- FTK 0.77
- HQL 0.19
- MACD
- FTK 0.23
- HQL 0.01
- Stochastic Oscillator
- FTK 47.11
- HQL 100.00
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.